ISCT 2023 Paris Annual Meeting

ISCT 2023 Paris is the event of the year to connect with the global CGT community, with a core focus on cell and gene therapy translation. Taking place in Palais des Congres de Paris from 31 May – 3 June 2023, the ISCT Annual Meeting takes an integrative approach across all stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialisation and ultimately patient access. Topics are curated to address the biggest bottlenecks in cell and gene therapy development.

We are pleased to announce that three TTP Group companies will be participating at ISCT 2023.

For over 30 years, TTP has been helping some of the world’s most innovative and ambitious companies develop new tools and technologies in advanced therapy manufacture and process analytics. We work across the cell and gene therapy ecosystem, from therapy developers to tools companies. To find out more, visit: www.ttp.com/industries/life-science/cell-and-gene-therapy/. Stuart Lowe, Steve Taylor and Debbie McArthur from the Cell and Gene team at TTP will be in attendance, please book a meeting with them through the ISCT partnering app.

Cellular Origins will be exhibiting on Booth 4

Cellular Origins, a TTP Company, is focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies. Working closely with therapeutic developers to access the equipment they want, at the capacity they need, Cellular Origins’ robotic technology with automated sterile fluidic interconnection addresses the challenges associated with manufacturing at scale reduces cost and labour, eliminating human error, and increasing efficiency. www.cellularorigins.com

Cellular Highways will be exhibiting on Booth 20

Cellular Highways is a spin-out from TTP plc, based in Melbourn Science Park, just south of Cambridge, UK. We have created Cellular Highways to take cell sorting into new medical and research applications, where previous cell sorting technology has failed. Our growing team of scientists and engineers is currently working on our first product, Highway1, pilot-scale manufacturing of our MEMS sorter chip and scaling of the technology to parallel sorting systems. www.cellularhighways.com

If you would like to arrange a meeting with Cellular Origins, Cellular Highways, or the TTP Cell and Gene team, please contact us on enquiries@ttp.com. We hope to see you at ISCT 2023!